Usefulness of a Modified Inflammation-Based Prognostic System for Predicting Postoperative Mortality of Patients Undergoing Surgery for Primary Hepatocellular Carcinoma

被引:44
作者
Ishizuka, Mitsuru [1 ]
Kubota, Keiichi [1 ]
Kita, Junji [1 ]
Shimoda, Mitsugi [1 ]
Kato, Masato [1 ]
Sawada, Tokihiko [1 ]
机构
[1] Dokkyo Med Univ, Dept Surg Gastroenterol, Mibu, Tochigi 3210293, Japan
关键词
Cancer of the Liver Italian Program score; Glasgow Prognostic Score; hepatocellular carcinoma; scoring system; systemic inflammatory response; CELL LUNG-CANCER; COLORECTAL-CANCER; SCORE GPS; CLIP SCORE; SERUM INTERLEUKIN-6; PERFORMANCE STATUS; HEPATIC RESECTION; STAGING SYSTEMS; GASTRIC-CANCER; SURVIVAL;
D O I
10.1002/jso.21857
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To assess and compare the predictive values of the hepatic Glasgow Prognostic Score (hGPS) and Cancer of the Liver Italian Program (CLIP) score in patients undergoing surgery for primary hepatocellular carcinoma (HCC). Methods : The hGPS was calculated as follows: patients with an elevated level of C-reactive protein (CRP) (>0.3 mg/dl) were allocated a hGPS of 1 or 2 depending on the absence or presence of hypoalbuminemia (<3.5 g/dl), and patients without an elevation of the CRP level (<= 0.3 mg/dl) were allocated a hGPS of 0. Results : Three hundred patients were evaluated. The hGPS divided patients into three independent groups, and that a hGPS of 2 predicted a higher mortality rate (P < 0.001) than a hGPS of 0 or 1. Univariate analysis demonstrated that hGPS (0, 1/2) (P = 0.010) was one of the factors predictive of postoperative mortality, along with the CLIP score (0, 1/>= 2) (P = 0.021). Comparative analysis using these two factors showed that the hGPS was predictively superior to the CLIP score (P = 0.033). Conclusions : The hGPS is able to divide patients undergoing surgery for primary HCC into three independent groups, and is considered to be an important factor predictive of postoperative mortality in such patients. J. Surg. Oncol. 2011; 103:801-806. (C) 2011 Wiley-Liss, Inc.
引用
收藏
页码:801 / 806
页数:6
相关论文
共 39 条
[1]   Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer [J].
Al Murri, AM ;
Bartlett, JMS ;
Canney, PA ;
Doughty, JC ;
Wilson, C ;
McMillan, DC .
BRITISH JOURNAL OF CANCER, 2006, 94 (02) :227-230
[2]  
[Anonymous], HEPATOLOGY
[3]   A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma [J].
Cho, Clifford S. ;
Gonen, Mithat ;
Shia, Jinru ;
Kattan, Michael W. ;
Klimstra, David S. ;
Jarnagin, William R. ;
D'Angelica, Michael I. ;
Blumgart, Leslie H. ;
DeMatteo, Ronald P. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2008, 206 (02) :281-291
[4]   Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer [J].
Crozier, Joseph E. M. ;
Leitch, E. Fiona ;
McKee, Ruth F. ;
Anderson, John H. ;
Horgan, Paul G. ;
McMillan, Donald C. .
AMERICAN JOURNAL OF SURGERY, 2009, 197 (04) :544-549
[5]   Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer [J].
Crumley, ABC ;
McMillan, DC ;
McKernan, M ;
McDonald, AC ;
Stuart, RC .
BRITISH JOURNAL OF CANCER, 2006, 94 (05) :637-641
[6]   Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer [J].
Elahi, MM ;
McMillan, DC ;
McArdle, CS ;
Angerson, WJ ;
Sattar, N .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2004, 48 (02) :171-173
[7]  
Farinati F, 2000, CANCER, V89, P2266, DOI 10.1002/1097-0142(20001201)89:11<2266::AID-CNCR15>3.0.CO
[8]  
2-0
[9]   A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer [J].
Forrest, LM ;
McMillan, DC ;
McArdle, CS ;
Angerson, WJ ;
Dagg, K ;
Scott, HR .
BRITISH JOURNAL OF CANCER, 2005, 92 (10) :1834-1836
[10]   Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer [J].
Forrest, LM ;
McMillan, DC ;
McArdle, CS ;
Angerson, WJ ;
Dunlop, DJ .
BRITISH JOURNAL OF CANCER, 2004, 90 (09) :1704-1706